Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer

被引：0

作者：

AW Partin

MK Brawer

ENP Subong

CA Kelley

JL Cox

DJ Bruzek

J Pannek

GE Meyer

DW Chan

机构：

[1] The Brady Urological Institute,Department of Urology

[2] The Johns Hopkins Hospital,Department of Pathology

[3] The Brady Urological Institute,undefined

[4] The Johns Hopkins Hospital,undefined

[5] The University of Washington and Seattle Veterans Affairs Administration Medical Center,undefined

来源：

Prostate Cancer and Prostatic Diseases | 1998年 / 1卷

关键词：

prostate cancer; detection; percent ; -PSA; complexed-PSA; prospective;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Aims of the study: Retrospective studies investigating the use of percent free-PSA for early detection of prostate cancer were limited for various reasons: by their use of long-term stored sera, poor mix of non-cancer to cancer cases and the use of only men with PSA values between 4.0 and 10.0 ng/mL. This prospective study investigates the clinical utility of percent free-PSA and complexed-PSA for early detection of prostate cancer in 219 consecutive men presenting for prostate biopsy.

引用

页码：197 / 203

页数：6

共 50 条

[41] Correlation of prostate volume and percent free PSA in prostate cancer detection in men with a total PSA 2.6-10.0 ng/ml
Bruno, JJ
Armenakas, NA
Fracchia, JA
JOURNAL OF UROLOGY, 2006, 175 (04): : 478 - 479
[42] Complexed PSA for early detection of prostate cancer in men with serum PSA values of 2-4 ng/mL.
Cheli, CD
Horninger, W
Babaian, R
Fritsche, H
Taneja, S
Lepor, H
Sokoll, L
Chan, D
Childs, S
CLINICAL CHEMISTRY, 2002, 48 (06) : A15 - A15
[43] Staging of prostate cancer with Complex PSA and Complex PSA indices, free PSA ratio, PSAD and PSATZ: Results of the prospective European prostate cancer detection and staging study
Djavan, B
Zlotta, A
Horninger, W
Ravery, V
Hammerer, P
Kairary, A
Dobronski, P
Reissigl, A
Remzi, M
Schulman, C
Gibod, LB
Bartsch, G
Marberger, M
JOURNAL OF UROLOGY, 2003, 169 (04): : 341 - 342
[44] PSA density as a better predictor of prostate cancer than percent-free PSA in a repeat biopsy
Chen, Chuan-Shu
Wang, Shian-Shiang
Li, Jian-Ri
Cheng, Chen-Li
Yang, Chi-Rei
Chen, Wen-Ming
Ou, Yen-Chuan
Ho, Hao-Chung
Chiu, Kun-Yuan
Yang, Cheng-Kuang
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2011, 74 (12) : 552 - 555
[45] PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/ml
Djavan, B
Zlotta, A
Kratzik, C
Remzi, M
Seitz, C
Schulman, CC
Marberger, M
UROLOGY, 1999, 54 (03) : 517 - 522
[46] Free to complexed PSA ratio in differentiating benign prostate hyperplasia from prostate cancer
Filella, X
Alcover, J
Corral, JM
Molina, R
Beardo, P
Ballesta, AM
ANTICANCER RESEARCH, 2001, 21 (05) : 3717 - 3720
[47] Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: Which is clinically effective and when?
Basso, D
Fogar, P
Piva, MG
Navaglia, F
Mazza, S
Prayer-Galetti, T
Castellucci, E
Pagano, F
Plebani, M
UROLOGY, 2000, 55 (05) : 710 - 715
[48] Final results of the prospective European multicenter study of complex PSA and complex PSA indices for early prostate cancer detection
Djavan, B
Zlotta, A
Ravery, V
Hammerer, P
Kaisary, A
Dobronski, P
Reissigl, A
Remzi, M
Schulman, C
Gibod, LB
Marberger, M
JOURNAL OF UROLOGY, 2003, 169 (04): : 383 - 383
[49] Cost-effectiveness of percent free PSA for prostate cancer detection in men with a total PSA of 4-10 ng/ml
Bermudez-Tamayo, Clara
Martin Martin, Jose Jesus
Lopez del Amo Gonzalez, Maria Del Puerto
Perez Romero, Carmen
UROLOGIA INTERNATIONALIS, 2007, 79 (04) : 336 - 344
[50] PSA-based early detection of prostate cancer
Luboldt, HJ
Rübben, H
UROLOGE A, 2000, 39 (01): : 22 - 26

← 1 2 3 4 5 →